Belvedere Trading »

SPDR S&P Pharmaceuticals shares owned by Belvedere Trading

Quarter-by-quarter ownership of SPDR S&P Pharmaceuticals (XPH) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in SPDR S&P Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Pharmaceuticals held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Pharmaceuticals by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2026-06-30 $219k 3.3k 66.27

More positions owned by Belvedere Trading

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Sandisk Corp (SNDK)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold SHS (GLD)
Intel Corporation (INTC)

View all positions for Belvedere Trading

Top funds holding SPDR S&P Pharmaceuticals

Bank of America Corporation
CWM
Wells Fargo & Company
Kingsview Wealth Management
Morgan Stanley
Envestnet Asset Management
First Citizens Bank & Trust
Envestnet Portfolio Solutions
LPL Financial
Branch Banking & Trust Company
Measured Wealth Private Client Group
Private Advisor
UBS Group
Susquehanna International
Citigroup

View all funds holding SPDR S&P Pharmaceuticals